Jeff Yass’s Xenon Pharmaceuticals XENE Stock Holding History
Bought
Maintained
Sold
Other funds holding XENE
Jeff Yass's XENE Position: Q3 2026 in Review
Jeff Yass increased its Xenon Pharmaceuticals (XENE) stake by 227% in Q3 2026, buying an estimated $3M and bringing the position to 72,819 shares worth $2.71M. The position accounts for ﹤0.01% of the portfolio, ranked #5635.
Jeff Yass first reported a position in XENE in Q2 2017 and has held it in 17 quarters since. The position peaked at $10.3M in Q1 2026. 288 funds tracked by Wall St. Rank hold XENE as of Q3 2026.
- Jeff Yass held 72,819 shares of Xenon Pharmaceuticals worth $2.71M as of Q3 2026.
- Jeff Yass bought 50,561 Xenon Pharmaceuticals shares in Q3 2026, an estimated $3M.
- Xenon Pharmaceuticals made up ﹤0.01% of Jeff Yass's portfolio in Q3 2026, its #5635 holding.
- Jeff Yass first reported a position in Xenon Pharmaceuticals in Q2 2017 and has held it in 17 quarters since.
- Jeff Yass's Xenon Pharmaceuticals position peaked at $10.3M in Q1 2026.
- 288 funds tracked by Wall St. Rank held Xenon Pharmaceuticals as of Q3 2026.
Based on Susquehanna International Group's 13F filing for Q3 2026, filed 16 Nov 2026.